Intuniv Antitrust Settlement



If your pharmacy or entity purchased brand or generic Intuniv directly from a manufacturer, you may be entitled to a portion of the $19.9 Million thus far recovered in this class action settlement.



Settlement Amount: $19,900,000


SIGN UP TO PARTICIPATE

Class Members:



All entities in the United States and its territories, or subsets thereof, that purchased Intuniv and/or generic Intuniv in any form directly from Shire or Actavis, including any predecessor or successor of Shire or Actavis, from October 19, 2012 through June 1, 2015 (the “Class”).


Excluded from the Class are Shire, Actavis, and any of their officers, directors, management, employees, subsidiaries, and affiliates, as well as governmental entities.



Damage Period:



  • October 19,2012 through June 1, 2015 (Branded Intuniv)
  • December 1, 2014 through June 1, 2015 (Generic Intuniv)


Claim Based on:



Combined total net purchases of brand Intuniv from November 15, 2012 through February 29, 2016 and generic Intuniv from December 1, 2014 through June 1, 2015



Eligible Jurisdictions:



United States, its territories and possessions including the Commonwealth of Puerto Rico



Background:



Plaintiffs allege that Shire and Actavis entered into an agreement by which Shire paid Actavis in exchange for Actavis to delay selling its generic version of Intuniv in violation of federal antitrust laws


The Lawsuit alleges that this unlawful scheme delayed and impeded the market entry of less expensive, generic versions of Intuniv and as a result members of the Direct Purchaser Class paid higher prices for their purchases of brand and generic Intuniv than they otherwise would have.


Shire and Actavis deny all of these allegations, including that any Class member is entitled to damages or other relief. Shire and Actavis also maintain that none of their conduct violated any applicable law or regulation. ​



Defendants:



Shire plc, Shire LLC, and Shire U.S., Inc. (“Shire”) and Actavis Elizabeth LLC, Actavis LLC, and Actavis Holdco US, Inc. (“Actavis”)​



Deadlines:



  • To object: November 20, 2020 (passed)
  • Fairness hearing: December 9, 2020 (passed)


This is not an official Court Notice. Information contained in this Summary is subject to change.



CLASS ACTION REFUND, LLC





7901 4th Street N, Suite 13892
Saint Petersburg, FL 33702
PH: (727) 266-0433



Class Action Refund Center and the green arrow are trademarks of Class Action Refund, LLC a Florida Limited Liability Company.

Not affiliated with Class Action Recovery, LLC dba Class Action Refund in Harrison, NY